Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Autor: Godman, Brian, Hill, Andrew, Simoens, Steven, Selke, Gisbert, Selke Krulichová, Iva, Zampirolli Dias, Carolina, Martin, Antony P., Oortwijn, Wija, Timoney, Angela, Gustafsson, Lars L., Vončina, Luka, Kwon, Hye-Young, Gulbinovič, Jolanta, Gotham, Dzintars, Wale, Janet, Cristina Da Silva, Wânia, Bochenek, Tomasz, Allocati, Eleonora, Kurdi, Amanj, Ogunleye, Olayinka O., Meyer, Johanna C., Hoxha, Iris, Malaj, Admir, Hierländer, Christian, Sauermann, Robert, Hamelinck, Wouter, Petrova, Guenka, Laius, Ott, Langner, Irene, Yfantopoulos, John, Joppi, Roberta, Jakupi, Arianit, Greičiūtė-Kuprijanov, Ieva, Bonanno, Patricia Vella, Piepenbrink, Jf, de Valk, Vincent, Wladysiuk, Magdalene, Markovic-Pekovic, Vanda, Mardare, Ileana, Fürst, Jurij, Tomek, Dominik, Obach Cortadellas, Mercè, Zara, Corinne, Pontes, Caridad, McTaggart, Stuart, Laba, Tracey-Lea, Melien, Øyvind, Wong-Rieger, Durhane, Bae, SeungJin, Hill, Ruaraidh

Externí odkaz: https://hdl.handle.net/11250/2990037

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.

Autor: Godman B; Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia., Hill A; Institute of Translational Medicine, University of Liverpool, UK., Simoens S; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium., Selke G; Wissenschaftliches Institut Der AOK (WIdO), Berlin, Germany., Selke Krulichová I; Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Hradec, Králové, Czech Republic., Zampirolli Dias C; Faculty of Pharmacy, Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.; SUS Collaborating Centre for Technology Assessment and Excellence in Health (CCATES), Belo Horizonte, Minas Gerais, Brazil., Martin AP; Faculty of Health and Life Sciences, Liverpool, UK.; QC Medica, Sim Balk Lane, York UK., Oortwijn W; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Timoney A; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; NHS Lothian, Edinburgh, UK., Gustafsson LL; Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden., Voncina L; Faculty of Health Studies, Rijeka, Croatia., Kwon HY; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Division of Biology & Public Health, Mokwon University, Daejeon, Korea., Gulbinovic J; Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Gotham D; Independent Researcher, Boston, MA, United States., Wale J; Independent Consumer Advocate, Brunswick, Victoria, Australia., Cristina Da Silva W; Faculty of Pharmacy, Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.; Data and Knowledge Integration Center for Health(CIDACS), Fundação Oswaldo Cruz (FIOCRUZ)/ Salvador, Bahia, Brazil., Bochenek T; Department of Nutrition and Drug Research, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Allocati E; Istituto Di Ricerche Farmacologiche 'Mario Negri' IRCCS, Milan, Italy., Kurdi A; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq., Ogunleye OO; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.; Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Meyer JC; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa., Hoxha I; Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania., Malaj A; University of Medicine, Tirana, Albania., Hierländer C; Department of Pharmaceutical Affairs, Federation of Social Insurances, Vienna, Austria., Sauermann R; Department of Pharmaceutical Affairs, Federation of Social Insurances, Vienna, Austria., Hamelinck W; Statistics Department, Bruxelles, Belgium., Petrova G; Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria., Laius O; State Agency of Medicines, Tartu, Estonia., Langner I; Wissenschaftliches Institut Der AOK (WIdO), Berlin, Germany., Yfantopoulos J; School of National and Kapodistrian University of Athens Athens Greece., Joppi R; Pharmaceutical Drug Department, Azienda Sanitaria Locale of Verona, Verona, Italy., Jakupi A; Faculty of Pharmacy, UBT - Higher Education Institution, Prishtina, Kosovo., Greiciute-Kuprijanov I; Department of Pharmacy, Ministry of Health of the Republic of Lithuania, Vilnius, Lithuania., Vella Bonanno P; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK., Piepenbrink JH; National Health Care Institute (ZIN), XH, Diemen, Netherlands., de Valk V; National Health Care Institute (ZIN), XH, Diemen, Netherlands., Wladysiuk M; HTA Consulting, Cracow, Poland., Marković-Peković V; Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina., Mardare I; Faculty of Medicine, Public Health and Management Department, 'Carol Davila' University of Medicine and Pharmacy Bucharest, Bucharest, Romania., Fürst J; Health Insurance Institute, Ljubljana, Slovenia., Tomek D; Faculty of Medicine, Slovak Medical University in Bratislava, Bratislava, Slovakia., Obach Cortadellas M; Drug Department, Catalan Health Service, Catalan Health Service, Barcelona, Spain., Zara C; Drug Department, Catalan Health Service, Catalan Health Service, Barcelona, Spain., Pontes C; Drug Department, Catalan Health Service, Catalan Health Service, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma De Barcelona, Barcelona, Spain., McTaggart S; Public Health Scotland, Edinburgh, UK., Laba TL; Centre for Health Economics Research and Evaluation, University of Technology Sydney, Broadway, Sydney, NSW., Melien Ø; Reviews and Health Technology Assessments, Norwegian Institute of Public Health, Oslo, Norway., Wong-Rieger D; Health Data Science, Institute of Population Health, Liverpool, Canadian Organization for Rare Disorders, Toronto, Ontario, Canada., Bae S; College of Pharmacy, Ewha Woman's University, Seoul, South Korea., Hill R; Health Data Science, Institute of Population Health Liverpool Reviews and Implementation Group, Whelan Building, University of Liverpool, Liverpool, UK.

Publikováno v: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2021 Aug; Vol. 21 (4), pp. 527-540. Date of Electronic Publication: 2021 Mar 11.